Literature DB >> 16990657

Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects.

Michael Højby Rasmussen1, Anders Juul, Lise Lund Kjems, Jannik Hilsted.   

Abstract

OBJECTIVE: Decreased levels of GH and total IGF-I have been reported in obesity. It has been hypothesized that increased free (biologically active) IGF-I levels generated from IGF-binding protein (IGFBP) protease activity could be the mechanism for the low GH release in dieting obese subjects. However, no published data exist on free IGF-I levels, acid labile subunit (ALS), or IGFBP protease activity in relation to GH release during a hypocaloric diet. The main purpose of this study was to determine free IGF-I, ALS, IGFBPs-1-4, and IGFBPs-1-3 protease activity in relation to 24-h GH release before and after a short-term very low-calorie diet (VLCD).
DESIGN: Six obese subjects before weight loss, five after an average weight loss of 36.1 kg, and five age-and sex-matched lean controls underwent a 4-day VLCD. All subjects were studied on two occasions, once during normal basic diet and again during the last day of the VLCD (1.6 MJ).
METHODS: Free IGF-I was determined by a non-competitive immunoradiometric assay.
RESULTS: Free IGF-I levels decreased in concert with increased ALS and unchanged blunted GH release after a VLCD in the obese subjects. IGFBPs-1-3 proteolytic activity was found to be unchanged by hypocaloric diet in all groups.
CONCLUSIONS: We conclude that free IGF-I decreases after a short-term hypocaloric diet in obese subjects with no concomitant change in 24-h GH release. Circulating free IGF-I per se cannot be the main mechanism of the attenuated GH release in dieting obese subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990657     DOI: 10.1530/eje.1.02246

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

1.  Changes in plasma levels of ghrelin, leptin, and other hormonal and metabolic parameters following standardized breakfast, lunch, and physical exercise before and after a multidisciplinary weight-reduction intervention in obese adolescents.

Authors:  A E Rigamonti; F Agosti; A De Col; N Marazzi; C L Lafortuna; S G Cella; E E Muller; A Sartorio
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

2.  Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia.

Authors:  Andrea S Cornford; Ariel L Barkan; Jeffrey F Horowitz
Journal:  J Clin Endocrinol Metab       Date:  2011-01-05       Impact factor: 5.958

3.  Acute and short-term effects of caloric restriction on metabolic profile and brain activation in obese, postmenopausal women.

Authors:  S Jakobsdottir; I C van Nieuwpoort; C C van Bunderen; M B de Ruiter; J W R Twisk; J B Deijen; D J Veltman; M L Drent
Journal:  Int J Obes (Lond)       Date:  2016-05-24       Impact factor: 5.095

4.  Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity.

Authors:  Chunxia Lu; P Anil Kumar; Jinhong Sun; Anjali Aggarwal; Yong Fan; Mark A Sperling; Carey N Lumeng; Ram K Menon
Journal:  J Biol Chem       Date:  2013-04-17       Impact factor: 5.157

Review 5.  The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.

Authors:  Marwan Maalouf; Jong M Rho; Mark P Mattson
Journal:  Brain Res Rev       Date:  2008-09-25

Review 6.  Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence.

Authors:  Michelle N Harvie; Tony Howell
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

7.  The intricate role of growth hormone in metabolism.

Authors:  Archana Vijayakumar; Shoshana Yakar; Derek Leroith
Journal:  Front Endocrinol (Lausanne)       Date:  2011-09-27       Impact factor: 5.555

8.  Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome.

Authors:  Davide Francomano; Andrea Lenzi; Antonio Aversa
Journal:  Int J Endocrinol       Date:  2014-02-12       Impact factor: 3.257

Review 9.  Utility of free IGF-I measurements.

Authors:  Jan Frystyk
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

Review 10.  The insulin-like growth factor system and nutritional assessment.

Authors:  Callum Livingstone
Journal:  Scientifica (Cairo)       Date:  2012-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.